Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone

British Journal of Pharmacology

Volumn 121, Issue 5, 1997, Pages 883-888

  Ferreira, S H ^a   Cunha, F Q ^a   Lorenzetti, B B ^a   Michelin, M A ^a   Perretti, M ^b   Flower, R J ^b   Poole, S ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Annexin 1; Bradykinin; Dexamethasone; Inflammatory hyperalgesia; Interleukin 1; Interleukin 6; Interleukin 8; Prostaglandins; Tumour necrosis factor

Indexed keywords

ANTISERUM; ARACHIDONIC ACID; BRADYKININ; CARRAGEENAN; CYCLOOXYGENASE 2; DEXAMETHASONE; DOPAMINE; GLUCOCORTICOID; ICOSANOID; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOCORTIN 1; LIPOPOLYSACCHARIDE; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; ENZYME INHIBITION; HYPERALGESIA; MACROPHAGE; MALE; NONHUMAN; PREVENTION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANNEXIN A1; ANTI-INFLAMMATORY AGENTS; ANTIBODIES; CELL LINE; DEXAMETHASONE; DINOPROSTONE; HUMANS; HYPERALGESIA; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; NOCICEPTORS; PAIN MEASUREMENT; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031008485     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701211     Document Type: Article

References (29)

1. AUPHAN, N., DIDONATO, J.A., ROSETTE, C., HELMBERG, A. & KARIN, M. (1995). Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science, 270, 286-290.
2. BARNES, P.J. (1996). Molecular mechanisms of steroid action in asthma. J. Allergy Clin. Immunol., 97, 159-168.
3. BARTON, B.E., JAKAWAY, J.P., SMITH, S.R. & SIEGEL, M.I. (1991). Cytokine inhibition by a novel steroid, mometasone furoate. Immunopharmacol. Immunoloxicol., 13, 251-261.
4. BLACKWELL, G.J., CARNUCCIO, R., DIROSA, M., FLOWER, R.J., PARENTE, L. & PERISCO, P. (1980). Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoid drugs. Nature 187, 147-149.
5. COCKERILL, P.N., SHANNON, M.F., BERT, A.G., RYAN, G.R. & VADAS, M.A. (1993). The granulocyte-macrophage colony stimulating factor/interleukin-3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc. Natl. Acad. Sci. U.S.A., 90, 2466-2470.
6. CUNHA, F.Q., POOLE, S., LORENZETTI, B.B. & FERREIRA, S.H. (1992). The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br. J. Pharmacol., 107, 660-664.
7. CUNHA, F.Q., BOUKILI, M.A., BRAGA DA MOTTA, J.I., VARGAFTIG, B.B. & FERREIRA, S.H. (1993). Blockade by fenspiride of endotoxin-induced neutrophil migration in the rat. Eur. J. Pharmacol., 238, 47-52.
8. FERREIRA, S.H., LORENZETTI, B.B. & CORREA, F.M.A. (1978). Central and peripheral antialgesic action of aspirin-like drugs. Eur. J. Pharmacol., 53, 39-48.
9. FERREIRA, S.H., LORENZETTI, B.B. & POOLE, S. (1993). Bradykinin initiates cytokine mediated inflammatory hyperalgesia. Br. J. Pharmacol., 110, 1227-1231.
10. FLOWER, R.J. & BLACKWELL, G.J. (1979). Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature, 2708 (5703), 456-459.
11. FLOWER, R.J. & ROTHWELL, N.J. (1994). Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol. Sci., 15, 71-76.
12. GARABEDIAN, B.S., POOLE, S., ALLCHORNE, A., WINTER, J. & WOOLF, C.J. (1995). Interleukin-1β contributes to the inflammation-induced increase in nerve-growth factor levels and inflammatory hyperalgesia. Br. J. Pharmacol., 115, 1265-1275.
13. GENG, Y., BLANCO, F.J., CORNELISSON, M. & LOTZ, M. (1995). Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. J. Immunol., 155, 796-801.
14. 2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc. Natl. Acad. Sci. U.S.A., 77, 2533-2536.
15. LEW, W., OPPENHEIM, J.J. & MATSUSHIMA, K. (1988). Analysis of the suppression of IL-1 alpha and IL-1 beta production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone. J. Immunol., 140, 1895-1902.
16. NAKAMURA, M. & FERREIRA, S.H. (1987). A peripheral sympathetic component in inflammatory hyperalgesia. Eur. J. Pharmacol., 135, 145-153.
17. PARK, J.-H., KAUSHANSKY, K., LEVITT, L. (1993). Transcriptional regulation of interleukin-3 in primary human lymphocytes. J. Biol. Chem., 268, 6299-6308.
18. PERRETTI, M., AHLUWALIA, A., HARRIS, J.G., GOULDING, N.J. & FLOWER, R.J. (1993). Lipocortin-1 fragments inhibit neutrophil-dependent edema in the mouse. J. Immunol., 151, 4306-4314.
19. PERRETTI, M., AHLUWALIA, A., HARRIS, J.G., HARRIS, H.J., WHELLER, S.K. & FLOWER, R.J. (1996). Acute inflammatory response in the mouse: exacerbation by immunoneutralization of lipocortin-1. Br. J. Pharmacol., 117, 1145-1154.
20. RELTON, J.K., STRIJBOS, P.J., O'SHAUGHNESSY, C.T., CAREY, F., FORDER, R.A., TILDERS, F.J. & ROTHWELL, N.J. (1991). Lipocortin-1 is an endogenous inhibitor of ischaemic damage in the rat brain. J. Exp. Med., 174, 305-310.
21. SALMON, J.A. (1978). A radioimmunoassay for 6-keto-prostaglandins F1-alpha. Prostaglandins, 5, 383-397.
22. SCHEINMAN, R.I., COGSWELL, P.C., LOFQUIST, A.K. & BALDWIN Jr, A.S. (1995). Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science, 270, 283-286.
23. SEITZ, M., DEWALD, B., GERBER, N. & BAGGIOLINI, M. (1991). Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J. Clin. Invest., 87, 463-469.
24. STEIN, B., BALDWIN, A.S., BALLARD, D.W., GREENE, W.C., ANGEL, P. & HERRLICH, P. (1993). Cross-coupling of the NF-κB p65 and Fos-Jun transcription factors produces potentiated biological function. EMBO J., 12, 3879-3891.
25. STERLING, E.A., BARTHELMÄS, R., PFEUFFER, I., SCHENK, B., ZARIUS, S., SWOBODA, R., MERCURIO, F. & KARIN, M. (1989). Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin-2 gene in T lymphocytes. EMBO J., 8, 465-473.
26. 2 and TNFα release from human peripheral blood mononuclear cells. Br. J. Pharmacol., 117, 1449-1456.
27. WAAGE, A. & BAKKE, O. (1988). Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology, 63, 299-302.
28. WOOLF, C.J., ALLCHORNE, A., GARABEDIAN, B.S. & POOLE, S. (1997). Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor α. Br. J. Pharmacol., (in press).
29. WOOLF, C.J., QING-PING, M.A., ALLCHORNE, A. & POOLE, S. (1996). Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J. Neurosci., 16, 2716-2723.